Aprea Therapeutics Files 2025 Proxy Statement
Ticker: APRE · Form: DEF 14A · Filed: Apr 22, 2025 · CIK: 1781983
| Field | Detail |
|---|---|
| Company | Aprea Therapeutics, Inc. (APRE) |
| Form Type | DEF 14A |
| Filed Date | Apr 22, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: APRE
TL;DR
Aprea Therapeutics (APRE) filed its proxy statement for the June 5th meeting. Key shareholder votes coming up.
AI Summary
Aprea Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 22, 2025, for its annual meeting on June 5, 2025. The filing covers the fiscal year ending December 31, 2024. The company is based in Doylestown, PA, and operates in the pharmaceutical preparations industry.
Why It Matters
This filing provides shareholders with crucial information regarding the company's governance, executive compensation, and proposals to be voted on at the upcoming annual meeting, impacting their investment decisions.
Risk Assessment
Risk Level: medium — Proxy statements often contain information about executive compensation, board structure, and shareholder proposals, which can indicate potential governance issues or strategic shifts.
Key Numbers
- 20250422 — Filing Date (Date the DEF 14A was filed with the SEC.)
- 20250605 — Meeting Date (Date of the Annual Meeting of Shareholders.)
Key Players & Entities
- Aprea Therapeutics, Inc. (company) — Registrant
- 20250422 (date) — Filing Date
- 20250605 (date) — Meeting Date
- 2024-12-31 (date) — Fiscal Year End
- Doylestown, PA (location) — Company Address
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the upcoming annual meeting on June 5, 2025, including details on voting matters, executive compensation, and corporate governance.
When is Aprea Therapeutics' fiscal year end?
Aprea Therapeutics' fiscal year ends on December 31.
Where is Aprea Therapeutics, Inc. located?
Aprea Therapeutics, Inc. is located at 3805 Old Easton Road, Doylestown, PA 18902.
What is the SEC Act under which this filing is made?
This filing is made under the Securities Exchange Act of 1934.
What is the SIC code for Aprea Therapeutics?
The Standard Industrial Classification (SIC) code for Aprea Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 22, 2025 regarding Aprea Therapeutics, Inc. (APRE).